Please assess the completion status of the following clinical trial:

Trial Title: Misoprostol Versus Dilapan-S for Cervical Preparation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* medically eligible for dilation and evacuation at Planned Parenthood League of Massachusetts~* gestational age 12 weeks 0 days to 15 weeks 0 days as evaluated by ultrasound~* proficient in English or Spanish~* agreeing to study procedures, including randomization and surveys regarding demographics, medical and gynecological history, and assessments of pain and satisfaction~Exclusion Criteria:~* less than 18 years old~* cervical or uterine anomaly that the research physician deems may affect the difficulty of dilation or the abortion procedure~* inflammatory bowel disease~* contraindication to misoprostol use~* known intolerance or allergy to misoprostol or Dilapan-S~* inability to give informed consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): 400mcg buccal misoprostol
- 2 (Type: EXPERIMENTAL): Dilapan-S, control: vitamin B-12 administered sublingually

Based on this trial design, predict the completion outcome and termination type (if applicable).